Exact Sciences Corporation shares rise 6.23% intraday after Senzime AB's TetraGraph® selected by California hospital system.

Exact Sciences Corporation rose 6.23% intraday, with the company's stock price increasing due to the announcement by Senzime AB (publ) that a leading university-based hospital system in California has selected Senzime’s TetraGraph® as its standard of care for neuromuscular monitoring. The agreement includes an initial order of 35 TetraGraph systems that will be deployed across the system’s operating rooms, supporting safe anesthesia management for more than 10,000 surgical patients annually.